Dr. Costas Yannakou, MD
Claim this profileEpworth Healthcare
Studies Cancer
Studies Myelofibrosis
4 reported clinical trials
8 drugs studied
Area of expertise
1Cancer
MYC positive
BCL2 positive
BCL6 positive
2Myelofibrosis
Clinical Trials Costas Yannakou, MD is currently running
DPX-Survivac + Pembrolizumab
for Lymphoma
This is a Phase 2b, randomized, open label study to assess the safety and efficacy of DPX-Survivac and pembrolizumab, with and without low-dose cyclophosphamide (CPA) in subjects with relapsed or refractory DLBCL.
Recruiting1 award Phase 2
APG-2575
for Blood Cancers
This is a multi-center, single-agent, open-label, Phase I study of APG-2575. The study consists of the dose escalation stage and the dose expansion stage.
Recruiting1 award Phase < 110 criteria
More about Costas Yannakou, MD
Clinical Trial Related4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Costas Yannakou, MD has experience with
- BMS-986158
- Fedratinib
- Ruxolitinib
- CB-5339
- APG-2575
- Cyclophosphamide
Breakdown of trials Costas Yannakou, MD has run
Myelodysplastic Syndrome
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Costas Yannakou, MD specialize in?
Costas Yannakou, MD focuses on Cancer and Myelofibrosis. In particular, much of their work with Cancer has involved MYC positive patients, or patients who are BCL2 positive.
Is Costas Yannakou, MD currently recruiting for clinical trials?
Yes, Costas Yannakou, MD is currently recruiting for 2 clinical trials in Melbourne Victoria. If you're interested in participating, you should apply.
Are there any treatments that Costas Yannakou, MD has studied deeply?
Yes, Costas Yannakou, MD has studied treatments such as BMS-986158, Fedratinib, Ruxolitinib.
What is the best way to schedule an appointment with Costas Yannakou, MD?
Apply for one of the trials that Costas Yannakou, MD is conducting.
What is the office address of Costas Yannakou, MD?
The office of Costas Yannakou, MD is located at: Epworth Healthcare, Melbourne, Victoria 3002 Australia. This is the address for their practice at the Epworth Healthcare.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.